c.i. 42510 has been researched along with Disease Models, Animal in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.17) | 18.7374 |
| 1990's | 1 (2.17) | 18.2507 |
| 2000's | 9 (19.57) | 29.6817 |
| 2010's | 31 (67.39) | 24.3611 |
| 2020's | 4 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Garré, JM; Lafaille, JJ; Silva, HM; Yang, G | 1 |
| Baluchnejadmojarad, T; Barati, H; Goudarzi, M; Jamali-Raeufy, N; Roghani, M | 1 |
| Adhikary, SR; Casolin, S; Cuthbertson, P; Geraghty, NJ; Sluyter, R; Watson, D | 1 |
| Chai, K; Deng, R; Ma, M | 1 |
| Britto, LR; de Souza, HD; Ferrazoli, EG; Nascimento, IC; Oliveira-Giacomelli, Á; Schwindt, TT; Ulrich, H | 1 |
| Almeida, FM; de Andrade, GM; Marques, SA; Martinez, AMB; Melo, PA; Oliveira, JT; Ribeiro, T; Tomaz, MA | 1 |
| Beker, M; Beker, MC; Caglayan, AB; Caglayan, B; Kelestemur, T; Kilic, E; Kilic, U; Ozturk, G; Sahin, F; Sertel, E; Yalcin, E | 1 |
| Feng, Y; Liu, H; Wan, YY; Wang, XW; Xu, KL; Zhao, K; Zhong, Q; Zhong, XM | 1 |
| Ainouche, S; Belzung, C; Camus, V; Farooq, RK; Roger, S; Tanti, A | 1 |
| Inukai, M; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Grygorowicz, T; Strużyńska, L | 1 |
| Bartlett, CA; Fitzgerald, M; Gopalasingam, G; Majimbi, M; Rodger, J; Toomey, LM | 1 |
| Ci, LL; Liu, ZN; Lv, XW; Su, QQ; Tian, YY | 1 |
| Geraghty, NJ; Sluyter, R; Watson, D | 1 |
| Barreto-Chaves, ML; Castelucci, P; Mendes, CE; Palombit, K; Tavares-de-Lima, W | 1 |
| Chen, S; Hu, Q; Krafft, PR; Ma, Q; Rolland, W; Sherchan, P; Tang, J; Zhang, J; Zhang, JH | 1 |
| Hagg, T; Kang, SS; Keasey, MP | 1 |
| Andrade, GM; Canas, PM; Carmo, MR; Cunha, RA; Menezes, AP; Nunes, AC; Palmeira, CM; Pliássova, A; Rolo, AP | 1 |
| Kovacic, P; Somanathan, R | 1 |
| Baker, AL; Cognetti, D; Curry, JM; Eisenbrey, JR; Goldberg, BB; Lally, S; Liu, JB; Merton, DA; Pluta, J; Pribitkin, EA; Rabinowitz, MP; Rabinowitz, MR; Saxena, S | 1 |
| Chang, L; Chen, X; Hu, J; Jiang, L; Wang, C; Wang, Q; Wei, X; Xu, S; Zhang, J; Zheng, B | 1 |
| Ohlsson, M; Ridderström, M | 1 |
| Deng, Y; Guo, XL; Liu, HG; Shang, J; Yuan, X; Zhu, D | 1 |
| Bohár, Z; Büki, A; Fejes-Szabó, A; László, AM; Nagy-Grócz, G; Párdutz, Á; Szabadi, N; Tar, L; Vécsei, L; Vraukó, V | 1 |
| Erisir, A; Irwin, JA; Kwon, I | 1 |
| Hoenerhoff, MJ; Pandiri, AR; Peddada, SD; Sills, RC; Yamashita, H | 1 |
| He, ZY; Luo, XG; Shang, H; Wang, XH; Xie, X | 1 |
| Alberch, J; Canals, JM; Díaz-Hernández, M; Díez-Zaera, M; Gómez-Villafuertes, R; Lucas, JJ; Miras-Portugal, MT; Sánchez-Nogueiro, J | 1 |
| Korenkov, M; Lang, H; Reber, H; Scholz, A; Schreckenberger, M; Shah, S; Viebahn, R | 1 |
| Allen, MR; Burr, DB | 1 |
| Bekar, L; Blum, L; Cotrina, ML; Goldman, SA; Han, X; Nedergaard, M; Peng, W; Takano, T; Tian, GF; Yu, H | 1 |
| Gültekin, E; Ozdemir, I; Yener, M | 1 |
| Buchanan, M; Gold, MS; Kobeissy, FH; Sadasivan, S; Wang, KK; Zhang, Z | 1 |
| Chen, T; Huang, DL; Kopelman, R; Orringer, DA; Philbert, M; Sagher, O | 1 |
| Jantaratnotai, N; McGeer, PL; McLarnon, JG; Ryu, JK; Serrano-Perez, MC | 1 |
| Forsberg, F; Goldberg, BB; Liu, JB; Merton, DA; Murphy, GF; Schanche, R; Schulz, S; Thakur, M; Waldman, SA; Zhang, K | 1 |
| Bramlett, HM; Dietrich, WD; Frydel, B; Marcillo, A | 1 |
| Arbeloa, J; Gottlieb, M; Matute, C; Pérez-Samartín, A | 1 |
| Aquino, JU; Beserra, HE; Cavalcante, RV; Cruz, DA; Pinheiro, LG; Rocha, JI; Vasques, PH | 1 |
| Chen, L; Gao, L; Mao, B; Piao, Y; Zeng, F | 1 |
| Andreana, S; Cornelini, R; Covani, U; Piattelli, A; Piattelli, M; Quaranta, A; Scarano, A | 1 |
| István, M; Lukács, L; Tóth, P | 1 |
| Gibbs, JF; Kahlenberg, MS; Kane, JM; Kanter, PM; Petrelli, NJ; Rodriguez-Bigas, MA; Weber, TK | 1 |
| Adamson, LK; Cho, K; Greenhalgh, DG; Hobson, KG | 1 |
| Levick, JR; Mason, RM; Sabaratnam, S | 1 |
| Greenhoot, JH; Mauck, HP; Shiel, FO | 1 |
1 review(s) available for c.i. 42510 and Disease Models, Animal
| Article | Year |
|---|---|
Toxicity of imine-iminium dyes and pigments: electron transfer, radicals, oxidative stress and other physiological effects.
Topics: Animals; Benzophenoneidum; Coloring Agents; Disease Models, Animal; Electron Transport; Humans; Imines; Indoles; Isoindoles; Methylene Blue; Oxidative Stress; Pheophytins; Pyocyanine; Reactive Oxygen Species; Rhodamines; Rosaniline Dyes; Trityl Compounds | 2014 |
1 trial(s) available for c.i. 42510 and Disease Models, Animal
| Article | Year |
|---|---|
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH.
Topics: Adenosine Triphosphate; Animals; Brain Edema; Carrier Proteins; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Injections, Intraventricular; Lipopolysaccharides; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Purinergic P2X7; RNA, Small Interfering; Rosaniline Dyes; Signal Transduction; Subarachnoid Hemorrhage | 2013 |
44 other study(ies) available for c.i. 42510 and Disease Models, Animal
| Article | Year |
|---|---|
P2X7 receptor inhibition ameliorates dendritic spine pathology and social behavioral deficits in Rett syndrome mice.
Topics: Animals; Brain; Dendritic Spines; Disease Models, Animal; Flow Cytometry; Male; Mice; Mice, Knockout; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rett Syndrome; Rosaniline Dyes | 2020 |
Combination therapy with dipeptidyl peptidase-4 and P2X7 purinoceptor inhibitors gives rise to antiepileptic effects in rats.
Topics: Animals; Anticonvulsants; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; DNA Fragmentation; Drug Therapy, Combination; Electroencephalography; Epilepsy; Gliosis; Hippocampus; Kainic Acid; Linagliptin; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Wistar; Rosaniline Dyes; Seizures; Treatment Outcome | 2020 |
P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model.
Topics: Adult; Animals; B-Lymphocytes; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukocytes, Mononuclear; Male; Mice, Inbred NOD; Mice, SCID; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2X7; Rosaniline Dyes; T-Lymphocytes, Regulatory | 2021 |
Study of the correlation between the noncanonical pathway of pyroptosis and idiopathic inflammatory myopathy.
Topics: Animals; Disease Models, Animal; Female; Glyburide; Guinea Pigs; Humans; Mice; Muscle, Skeletal; Myositis; Pyroptosis; Rosaniline Dyes | 2021 |
Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease.
Topics: Animals; Blotting, Western; Disease Models, Animal; Dopamine; Fenofibrate; Male; Parkinson Disease; Rats, Sprague-Dawley; Rosaniline Dyes; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Blockade of ATP P2X7 receptor enhances ischiatic nerve regeneration in mice following a crush injury.
Topics: Analgesics; Animals; Crush Injuries; Disease Models, Animal; Female; Ganglia, Spinal; Hyperalgesia; Interleukin-1alpha; Mice, Inbred C57BL; Motor Activity; Nerve Regeneration; Neuroprotective Agents; Peripheral Nerve Injuries; Peripheral Nerves; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Random Allocation; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord; Tumor Necrosis Factor-alpha | 2017 |
Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Brain; Brain Edema; Brain Ischemia; Calcium-Binding Proteins; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; DNA Fragmentation; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Neurons; Optic Nerve Injuries; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Rosaniline Dyes | 2017 |
[Effect of BBG on Acute Graft-Versus-Host Disease in Mice after Allogeneic Hematopoietic Stem Cell Transplantation].
Topics: Acute Disease; Animals; Cytokines; Disease Models, Animal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Interleukin-1beta; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Rosaniline Dyes | 2017 |
A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Dentate Gyrus; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred BALB C; Microglia; Neurogenesis; Neurosecretory Systems; Pituitary-Adrenal System; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Stress, Psychological | 2018 |
Brilliant Blue G protects against photoreceptor injury in a murine endotoxin-induced uveitis model.
Topics: Animals; Disease Models, Animal; Endotoxins; Male; Mice; Neuroprotective Agents; Photoreceptor Cells; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Retinal Pigment Epithelium; Rosaniline Dyes; Uveitis | 2018 |
Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis.
Topics: Animals; Brain; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Microglia; Multiple Sclerosis; Purinergic P2X Receptor Antagonists; Rats; Rats, Inbred Lew; Receptors, Purinergic P2X7; Rosaniline Dyes | 2019 |
Comparison of ion channel inhibitor combinations for limiting secondary degeneration following partial optic nerve transection.
Topics: Animals; Calcium Channel Blockers; Calcium-Binding Proteins; Cell Adhesion Molecules, Neuronal; Disease Models, Animal; Drug Delivery Systems; Drug Therapy, Combination; Ectodysplasins; Female; Imidazoles; Ion Channels; Macrophages; Microfilament Proteins; Microglia; Nerve Degeneration; Nystagmus, Optokinetic; Oligodendrocyte Transcription Factor 2; Optic Nerve Injuries; Piperazines; Quinoxalines; Rats; Receptor, Platelet-Derived Growth Factor alpha; Rosaniline Dyes; Tubulin | 2019 |
Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity.
Topics: Animals; Cytokines; Disease Models, Animal; Early Growth Response Protein 1; Fatty Liver, Alcoholic; Gastrointestinal Microbiome; Humans; Inflammation; Intestines; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Purinergic P2Y Receptor Antagonists; Pyridines; Rosaniline Dyes; Signal Transduction; Tetrazoles | 2019 |
Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease.
Topics: Animals; Cytokines; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatitis; Leukocytes; Liver; Mice; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes | 2019 |
Blockage of the P2X7 Receptor Attenuates Harmful Changes Produced by Ischemia and Reperfusion in the Myenteric Plexus.
Topics: Animals; Cytoprotection; Disease Models, Animal; Gastrointestinal Motility; Ileum; Male; Mesenteric Ischemia; Myenteric Plexus; Neurons; Neutrophil Infiltration; Purinergic P2X Receptor Antagonists; Rats, Wistar; Receptors, Purinergic P2X7; Reperfusion Injury; Rosaniline Dyes; Signal Transduction | 2019 |
P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Ciliary Neurotrophic Factor; Cytokines; Disease Models, Animal; Indicators and Reagents; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurogenesis; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Stroke | 2013 |
The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
Topics: Animals; Avoidance Learning; Brain; Cell Line, Tumor; Disease Models, Animal; Exploratory Behavior; Functional Laterality; Gliosis; Male; Maze Learning; Memory Disorders; Motor Activity; Neurotoxicity Syndromes; Oxidopamine; Parkinsonian Disorders; Purinergic P2X Receptor Antagonists; Rats; Rats, Wistar; Reaction Time; Rosaniline Dyes | 2014 |
Contrast-enhanced ultrasound-guided Sentinel lymph node biopsy of the ocular conjunctiva.
Topics: Animals; Conjunctiva; Conjunctival Neoplasms; Contrast Media; Disease Models, Animal; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Feasibility Studies; Ferric Compounds; Injections, Intraocular; Iron; Melanoma; Oxides; Random Allocation; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Swine; Technetium Tc 99m Sulfur Colloid | 2014 |
Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Newborn; Cells, Cultured; Cognition; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Hippocampus; Mice, Inbred ICR; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Pseudopodia; Rats, Sprague-Dawley; Rosaniline Dyes; Spatial Memory | 2014 |
Brilliant blue G treatment facilitates regeneration after optic nerve injury in the adult rat.
Topics: Animals; Axons; Cicatrix; Disease Models, Animal; Immunohistochemistry; Intermediate Filaments; Macrophages; Nerve Regeneration; Neuroglia; Neuroprotective Agents; Optic Nerve Injuries; Random Allocation; Rats, Sprague-Dawley; Rosaniline Dyes | 2014 |
P2X7 Receptor Antagonism Attenuates the Intermittent Hypoxia-induced Spatial Deficits in a Murine Model of Sleep Apnea Via Inhibiting Neuroinflammation and Oxidative Stress.
Topics: Animals; Disease Models, Animal; Hypoxia; Male; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Rosaniline Dyes; Sleep Apnea, Obstructive | 2015 |
Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.
Topics: Analgesics, Non-Narcotic; Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Drug Evaluation, Preclinical; Electric Stimulation; Facial Pain; Formaldehyde; Immunohistochemistry; Male; Nociceptive Pain; Proto-Oncogene Proteins c-fos; Purinergic P2X Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Trigeminal Ganglion; Vibrissae | 2015 |
Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Cell Death; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Neuroprotective Agents; Random Allocation; Rosaniline Dyes | 2016 |
Chemical Exacerbation of Light-induced Retinal Degeneration in F344/N Rats in National Toxicology Program Rodent Bioassays.
Topics: Acrylamide; Animals; Disease Models, Animal; Kava; Light; Rats; Rats, Inbred F344; Retinal Degeneration; Rosaniline Dyes | 2016 |
Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Imidazoles; Immunohistochemistry; Lipopolysaccharides; Male; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Protective Agents; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Rosaniline Dyes | 2017 |
Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.
Topics: Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Disease Models, Animal; Humans; Huntington Disease; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Rotarod Performance Test; Synapses | 2009 |
Laparoscopic radioisotope-guided sentinel lymph node mapping and excision of the rectum--an experimental study.
Topics: Animals; Coloring Agents; Disease Models, Animal; Gamma Cameras; Laparoscopy; Radionuclide Imaging; Radiopharmaceuticals; Rectum; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Swine; Technetium Tc 99m Aggregated Albumin | 2009 |
Mandibular necrosis in beagle dogs treated with bisphosphonates.
Topics: Alendronate; Alveolar Process; Animals; Bone Density Conservation Agents; Bone Matrix; Bone Remodeling; Cell Death; Cell Survival; Coloring Agents; Diphosphonates; Disease Models, Animal; Dogs; Female; Haversian System; Imidazoles; L-Lactate Dehydrogenase; Mandibular Diseases; Osteocytes; Osteonecrosis; Ribs; Rosaniline Dyes; Time Factors; Zoledronic Acid | 2009 |
Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury.
Topics: Adenosine Triphosphate; Animals; Disease Models, Animal; Humans; Indicators and Reagents; Neuroprotective Agents; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Recovery of Function; Rosaniline Dyes; Spinal Cord; Spinal Cord Injuries; Time Factors | 2009 |
The effect of topical Castellani solution on outer hair cell function of rats.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Disease Models, Animal; Ear, Middle; Follow-Up Studies; Gentamicins; Hair Cells, Auditory, Outer; Male; Otoacoustic Emissions, Spontaneous; Rats; Rats, Wistar; Rosaniline Dyes; Tympanic Membrane Perforation | 2010 |
Methods in systems biology of experimental methamphetamine drug abuse.
Topics: Animals; Cerebral Cortex; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Gene Expression Profiling; Immunoblotting; Injections; Male; Methamphetamine; Proteomics; Rats; Rats, Sprague-Dawley; Rosaniline Dyes; Substance-Related Disorders; Systems Biology | 2010 |
A technical description of the brain tumor window model: an in vivo model for the evaluation of intraoperative contrast agents.
Topics: Animals; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Disease Progression; Glioma; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Monitoring, Intraoperative; Rats; Rats, Sprague-Dawley; Rosaniline Dyes | 2011 |
Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Topics: Aged; Animals; Brain Neoplasms; Disease Models, Animal; Drug Delivery Systems; Gene Expression Regulation; Glioma; Growth Inhibitors; Humans; Male; Middle Aged; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tumor Cells, Cultured | 2011 |
Contrast-enhanced ultrasound imaging of sentinel lymph nodes after peritumoral administration of Sonazoid in a melanoma tumor animal model.
Topics: Animals; Chi-Square Distribution; Coloring Agents; Contrast Media; Disease Models, Animal; Ferric Compounds; Imaging, Three-Dimensional; Iron; Lymph Nodes; Lymphatic Metastasis; Melanoma; Oxides; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Statistics, Nonparametric; Swine; Technetium Tc 99m Sulfur Colloid; Ultrasonography; Videotape Recording | 2011 |
A reassessment of P2X7 receptor inhibition as a neuroprotective strategy in rat models of contusion injury.
Topics: Animals; Contusions; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Neuroprotective Agents; Purinergic P2X Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Spinal Cord Injuries | 2012 |
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Brain Injuries; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Fluoresceins; Glucose; Hypoxia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Membrane Potentials; N-Methylaspartate; Neurologic Examination; Neurons; Organic Chemicals; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Tetrazolium Salts | 2012 |
Experimental canine model for sentinel lymph node biopsy in the vulva using technetium and patent blue dye.
Topics: Animals; Coloring Agents; Disease Models, Animal; Dogs; Female; Gamma Rays; Inguinal Canal; Lymph Nodes; Radiopharmaceuticals; Reproducibility of Results; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium; Time Factors; Vulvar Neoplasms | 2012 |
pSVPoMcat modifying Schwann cell to protect injured spinal neurons in rats.
Topics: Acid Phosphatase; Animals; Apoptosis; Cell Transplantation; Disease Models, Animal; Evoked Potentials, Somatosensory; Female; Gene Transfer Techniques; Male; Methyl Green; Myelin Basic Protein; Nerve Regeneration; Rats; Rosaniline Dyes; Schwann Cells; Spinal Cord Injuries | 2002 |
Effect of enamel matrix derivative (Emdogain) on bone defects in rabbit tibias.
Topics: Animals; Benzenesulfonates; Bone Diseases; Bone Matrix; Bone Regeneration; Bone Substitutes; Coloring Agents; Dental Enamel Proteins; Disease Models, Animal; Osteoblasts; Rabbits; Rosaniline Dyes; Tibia; Time Factors; Tolonium Chloride; Wound Healing | 2004 |
Lymphonodal response to sensitization with 2,4-dinitrochlorobenzene (DNCB) in laboratory rats.
Topics: Animals; Antigens; Autoradiography; Dinitrochlorobenzene; Disease Models, Animal; DNA; Female; Injections, Intradermal; Irritants; Lymph Nodes; Lymphocyte Activation; Male; Organ Size; Radiopharmaceuticals; Rats; Rats, Inbred Strains; Rosaniline Dyes; Thymidine; Tritium | 1997 |
Hepatic lymphatic mapping: a pilot study for porta hepatis lymph node identification.
Topics: Animals; Blood Gas Analysis; Colorectal Neoplasms; Disease Models, Animal; Dogs; Liver; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Pilot Projects; Portal Vein; Prognosis; Rosaniline Dyes | 2001 |
Direct quantification of autologous serum albumin leakage after burn injury in mice.
Topics: Animals; Blotting, Western; Burns; Densitometry; Disease Models, Animal; Female; Indicators and Reagents; Mice; Mice, Inbred C57BL; Rosaniline Dyes; Serum Albumin; Severity of Illness Index; Time Factors | 2002 |
Inside-out cannulation of fine lymphatic trunks used to quantify coupling between transsynovial flow and lymphatic drainage from rabbit knees.
Topics: Albumins; Animals; Arthritis; Disease Models, Animal; Knee Joint; Lymph; Lymphatic System; Microcirculation; Models, Anatomic; Pressure; Rabbits; Rosaniline Dyes; Synovectomy; Synovial Fluid; Synovial Membrane; Time Factors | 2002 |
Experimental spinal cord injury. Electrocardiographic abnormalities and fuchsinophilic myocardial degeneration.
Topics: Animals; Arrhythmias, Cardiac; Atropine; Autonomic Nervous System; Blood Pressure; Disease Models, Animal; Dogs; Electrocardiography; Heart; Myocardium; Rosaniline Dyes; Spinal Cord Injuries; Staining and Labeling | 1972 |